Charles River Laboratories International, Inc. (CRL)
USD 183.16
(-3.26%)
USD 183.16
(-3.26%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 9.27 USD | -3.13% |
| 2022 | 9.57 USD | 23.17% |
| 2021 | 7.77 USD | 5.71% |
| 2020 | 7.35 USD | 42.17% |
| 2019 | 5.17 USD | 9.53% |
| 2018 | 4.72 USD | 81.54% |
| 2017 | 2.60 USD | -20.97% |
| 2016 | 3.29 USD | 2.49% |
| 2015 | 3.21 USD | 18.01% |
| 2014 | 2.72 USD | 26.51% |
| 2013 | 2.15 USD | 5.91% |
| 2012 | 2.03 USD | -6.02% |
| 2011 | 2.16 USD | 140.15% |
| 2010 | -5.38 USD | -407.43% |
| 2009 | 1.75 USD | 122.55% |
| 2008 | -7.76 USD | -435.93% |
| 2007 | 2.31 USD | 385.19% |
| 2006 | -0.81 USD | -139.71% |
| 2005 | 2.04 USD | 12.71% |
| 2004 | 1.81 USD | 2.84% |
| 2003 | 1.76 USD | 57.14% |
| 2002 | 1.12 USD | 30.23% |
| 2001 | 0.86 USD | 315.0% |
| 2000 | -0.40 USD | -146.51% |
| 1999 | 0.86 USD | -62.11% |
| 1998 | 2.27 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 1.75 USD | 23.24% |
| 2024 Q1 | 1.42 USD | -61.1% |
| 2023 Q4 | 3.65 USD | 114.71% |
| 2023 Q3 | 1.70 USD | -10.05% |
| 2023 Q2 | 1.89 USD | -6.44% |
| 2023 FY | - USD | -3.13% |
| 2023 Q1 | 2.02 USD | -45.11% |
| 2022 Q1 | 1.84 USD | -32.6% |
| 2022 Q3 | 1.90 USD | -11.63% |
| 2022 Q4 | 3.68 USD | 93.68% |
| 2022 FY | - USD | 23.17% |
| 2022 Q2 | 2.15 USD | 16.85% |
| 2021 Q3 | 2.05 USD | 16.48% |
| 2021 Q1 | 1.23 USD | -57.29% |
| 2021 Q4 | 2.73 USD | 33.17% |
| 2021 FY | - USD | 5.71% |
| 2021 Q2 | 1.76 USD | 43.09% |
| 2020 Q2 | 1.36 USD | 32.04% |
| 2020 FY | - USD | 42.17% |
| 2020 Q4 | 2.88 USD | 39.13% |
| 2020 Q3 | 2.07 USD | 52.21% |
| 2020 Q1 | 1.03 USD | -37.2% |
| 2019 Q4 | 1.64 USD | 10.07% |
| 2019 Q1 | 1.14 USD | -8.06% |
| 2019 Q2 | 0.90 USD | -21.05% |
| 2019 Q3 | 1.49 USD | 65.56% |
| 2019 FY | - USD | 9.53% |
| 2018 FY | - USD | 81.54% |
| 2018 Q3 | 1.25 USD | 12.61% |
| 2018 Q4 | 1.24 USD | -0.8% |
| 2018 Q2 | 1.11 USD | 0.91% |
| 2018 Q1 | 1.10 USD | 271.88% |
| 2017 Q3 | 1.11 USD | -1.77% |
| 2017 Q2 | 1.13 USD | 15.31% |
| 2017 Q1 | 0.98 USD | 3.16% |
| 2017 Q4 | -0.64 USD | -157.66% |
| 2017 FY | - USD | -20.97% |
| 2016 Q4 | 0.95 USD | 18.75% |
| 2016 Q1 | 0.80 USD | 15.94% |
| 2016 Q3 | 0.80 USD | 6.67% |
| 2016 Q2 | 0.75 USD | -6.25% |
| 2016 FY | - USD | 2.49% |
| 2015 FY | - USD | 18.01% |
| 2015 Q1 | 0.67 USD | 15.52% |
| 2015 Q2 | 1.04 USD | 55.22% |
| 2015 Q3 | 0.81 USD | -22.12% |
| 2015 Q4 | 0.69 USD | -14.81% |
| 2014 Q2 | 0.75 USD | 10.29% |
| 2014 Q4 | 0.58 USD | -17.14% |
| 2014 FY | - USD | 26.51% |
| 2014 Q1 | 0.68 USD | 65.85% |
| 2014 Q3 | 0.70 USD | -6.67% |
| 2013 FY | - USD | 5.91% |
| 2013 Q4 | 0.41 USD | -35.94% |
| 2013 Q3 | 0.64 USD | 12.28% |
| 2013 Q2 | 0.57 USD | 5.56% |
| 2013 Q1 | 0.54 USD | 38.46% |
| 2012 Q2 | 0.63 USD | 14.55% |
| 2012 FY | - USD | -6.02% |
| 2012 Q3 | 0.46 USD | -26.98% |
| 2012 Q1 | 0.55 USD | -1.79% |
| 2012 Q4 | 0.39 USD | -15.22% |
| 2011 Q1 | 0.58 USD | 109.6% |
| 2011 Q2 | 0.63 USD | 8.62% |
| 2011 Q3 | 0.38 USD | -39.68% |
| 2011 Q4 | 0.56 USD | 47.37% |
| 2011 FY | - USD | 140.15% |
| 2010 Q2 | 0.22 USD | -18.52% |
| 2010 FY | - USD | -407.43% |
| 2010 Q1 | 0.27 USD | 0.0% |
| 2010 Q3 | -0.39 USD | -277.27% |
| 2010 Q4 | -6.04 USD | -1448.72% |
| 2009 FY | - USD | 122.55% |
| 2009 Q1 | 0.39 USD | 103.94% |
| 2009 Q2 | 0.53 USD | 35.9% |
| 2009 Q3 | 0.57 USD | 7.55% |
| 2009 Q4 | 0.27 USD | -52.63% |
| 2008 Q4 | -9.89 USD | -1554.41% |
| 2008 FY | - USD | -435.93% |
| 2008 Q3 | 0.68 USD | -6.85% |
| 2008 Q2 | 0.73 USD | 12.31% |
| 2008 Q1 | 0.65 USD | 25.0% |
| 2007 Q2 | 0.57 USD | 3.64% |
| 2007 FY | - USD | 385.19% |
| 2007 Q1 | 0.55 USD | 5.77% |
| 2007 Q3 | 0.64 USD | 12.28% |
| 2007 Q4 | 0.52 USD | -18.75% |
| 2006 Q4 | 0.52 USD | 308.0% |
| 2006 Q1 | -1.40 USD | -302.9% |
| 2006 Q2 | 0.36 USD | 125.71% |
| 2006 FY | - USD | -139.71% |
| 2006 Q3 | -0.25 USD | -169.44% |
| 2005 Q1 | 0.42 USD | 40.0% |
| 2005 Q2 | 0.46 USD | 9.52% |
| 2005 Q3 | 0.45 USD | -2.17% |
| 2005 Q4 | 0.69 USD | 53.33% |
| 2005 FY | - USD | 12.71% |
| 2004 FY | - USD | 2.84% |
| 2004 Q1 | 0.38 USD | -5.0% |
| 2004 Q2 | 0.57 USD | 50.0% |
| 2004 Q3 | 0.56 USD | -1.75% |
| 2004 Q4 | 0.30 USD | -46.43% |
| 2003 FY | - USD | 57.14% |
| 2003 Q3 | 0.43 USD | -4.44% |
| 2003 Q4 | 0.40 USD | -6.98% |
| 2003 Q1 | 0.43 USD | 38.71% |
| 2003 Q2 | 0.45 USD | 4.65% |
| 2002 Q4 | 0.31 USD | -24.39% |
| 2002 Q3 | 0.41 USD | 10.81% |
| 2002 Q2 | 0.37 USD | 834.13% |
| 2002 Q1 | -0.05 USD | -126.53% |
| 2002 FY | - USD | 30.23% |
| 2001 Q1 | 0.19 USD | 72.73% |
| 2001 FY | - USD | 315.0% |
| 2001 Q4 | 0.19 USD | -20.83% |
| 2001 Q3 | 0.24 USD | 9.09% |
| 2001 Q2 | 0.22 USD | 15.79% |
| 2000 FY | - USD | -146.51% |
| 2000 Q4 | 0.11 USD | 115.94% |
| 2000 Q3 | -0.69 USD | -272.5% |
| 2000 Q1 | 0.03 USD | 0.0% |
| 2000 Q2 | 0.40 USD | 1233.33% |
| 1999 FY | - USD | -62.11% |
| 1998 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Agilent Technologies, Inc. | 4.22 USD | -119.668% |
| Quest Diagnostics Incorporated | 7.59 USD | -22.134% |
| Danaher Corporation | 6.44 USD | -43.944% |
| Enzo Biochem, Inc. | -0.51 USD | 1917.647% |
| IQVIA Holdings Inc. | 7.39 USD | -25.44% |
| Laboratory Corporation of America Holdings | 4.80 USD | -93.125% |
| Mettler-Toledo International Inc. | 36.10 USD | 74.321% |
| Qiagen N.V. | 1.54 USD | -501.948% |
| Revvity, Inc. | 5.56 USD | -66.727% |
| Thermo Fisher Scientific Inc. | 15.53 USD | 40.309% |
| Waters Corporation | 10.87 USD | 14.719% |